Division of Cardiology, Department of Internal Medicine, Oulu University Hospital, Oulu, Finland.
Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland.
Scand Cardiovasc J. 2020 Dec;54(6):358-360. doi: 10.1080/14017431.2020.1820563. Epub 2020 Sep 18.
We compared the ST elevation myocardial infarction (STEMI) incidence during COVID-19 pandemic (March 2020) to January-February 2020 and to same time period in earlier years 2017-2019 in five Nordic-Baltic tertiary centers. During 2017-2019, there were no marked differences in STEMI incidence between January, February and March. During 2020, there was an average drop of 32% in STEMI incidence in March. The isolation measures may decrease the risk for respiratory virus infection and contribute to the lower STEMI incidence and that we might benefit from firmer suggestions on hand hygiene and social distancing during flu season at least among high-risk individuals.
我们比较了 COVID-19 大流行（2020 年 3 月）期间与 2020 年 1 月至 2 月和前几年（2017-2019 年）在五个北欧-波罗的海三级中心的 ST 段抬高型心肌梗死（STEMI）发病率。在 2017-2019 年期间，1 月、2 月和 3 月 STEMI 发病率之间没有明显差异。在 2020 年，3 月 STEMI 发病率平均下降了 32%。隔离措施可能降低呼吸道病毒感染的风险，并导致 STEMI 发病率降低，我们可能受益于在流感季节至少对高危人群更坚定地建议手部卫生和保持社交距离。
